Cargando…
Increased risk of Graves´ophthalmopathy in patients with increasing TRAb after radioiodine treatment and the impact of CTLA4 on TRAb titres
INTRODUCTION: Treatment of Graves´ disease (GD) with radioiodine increases the risk of developing Graves´ ophthalmopathy (GO), and the link between thyroid and orbital tissue may be the presence of TSH-receptors. Radioiodine increases the titers of TRAb and the aim was to investigate the relationshi...
Autores principales: | Shahida, Bushra, Tsoumani, Kleoniki, Planck, Tereza, Modhukur, Vijayachitra, Asp, Pernilla, Sundlöv, Anna, Tennvall, Jan, Åsman, Peter, Lindgren, Ola, Lantz, Mikael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888513/ https://www.ncbi.nlm.nih.gov/pubmed/34859391 http://dx.doi.org/10.1007/s12020-021-02952-2 |
Ejemplares similares
-
The effect of radioiodine treatment on the characteristics of TRAb in Graves’ disease
por: Fang, Ya, et al.
Publicado: (2021) -
RhoA with Associated TRAb or FT3 in the Diagnosis and Prediction of Graves' Ophthalmopathy
por: Zhao, Sidi, et al.
Publicado: (2022) -
Thymic Involution After Radioiodine Therapy for Graves Disease: Relationships With Serum Thyroid Hormones and TRAb
por: Jinguji, Megumi, et al.
Publicado: (2017) -
Sampling trabecular meshwork using TrabEx+
por: Ramjiani, Vipul, et al.
Publicado: (2021) -
Thyrotropin Receptor Antibody (TRAb)-IgM Levels Are Markedly Higher Than TRAb-IgG Levels in Graves' Disease Patients and Controls, and TRAb-IgM Production Is Related to Epstein–Barr Virus Reactivation
por: Kumata, Keisuke, et al.
Publicado: (2016)